Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-05 Zimmermann Martine Director Shares withheld for taxes −182 $237.00 $43K 5,097
2026-06-05 Zimmermann Martine Director Grant or award · Non-Qualified Stock Option (right to buy) +2,938 2,938
2026-06-05 Sabba Stephen L Director Grant or award +836 33,629
2026-06-05 Sabba Stephen L Director Grant or award · Non-Qualified Stock Option (right to buy) +2,938 2,938
2026-06-05 LAMATTINA JOHN L Director Grant or award +836 31,560
2026-06-05 LAMATTINA JOHN L Director Grant or award · Non-Qualified Stock Option (right to buy) +2,938 2,938
2026-06-05 KOZARICH JOHN W Director Grant or award +836 42,622
2026-06-05 KOZARICH JOHN W Director Grant or award · Non-Qualified Stock Option (right to buy) +2,938 2,938
2026-06-05 Haas Jason Director Grant or award +836 7,442
2026-06-05 Haas Jason Director Grant or award · Non-Qualified Stock Option (right to buy) +2,938 2,938
2026-06-05 Gray Nancy Ryan Director Grant or award +836 8,930
2026-06-05 Gray Nancy Ryan Director Grant or award · Non-Qualified Stock Option (right to buy) +2,938 2,938
2026-06-01 Reardon Andrew CLO & Secretary Option exercise 10b5-1 +5,000 $52.27 $261K 46,382
2026-06-01 Reardon Andrew CLO & Secretary Sale 10b5-1 −491 $223.95 $110K 45,891
2026-06-01 Reardon Andrew CLO & Secretary Sale 10b5-1 −677 $225.20 $152K 45,214
2026-06-01 Reardon Andrew CLO & Secretary Sale 10b5-1 −1,432 $225.97 $324K 43,782
2026-06-01 Reardon Andrew CLO & Secretary Sale 10b5-1 −400 $226.78 $91K 43,382
2026-06-01 Reardon Andrew CLO & Secretary Sale 10b5-1 −584 $228.57 $133K 42,798
2026-06-01 Reardon Andrew CLO & Secretary Sale 10b5-1 −1,216 $229.47 $279K 41,582
2026-06-01 Reardon Andrew CLO & Secretary Sale 10b5-1 −200 $230.41 $46K 41,382

Page 6 of 43 · 858 trades